Article
eIF4G2-dependent translation restrains pancreatic cancer progression
2026-03-17
Abstract excerpt
<h4>ABSTRACT</h4> Pancreatic ductal adenocarcinoma (PDA) is among the most lethal cancers, driven by cellular plasticity that fuels therapeutic resistance and early dissemination. The contribution of translational control to this plasticity remains poorly understood. Through an in vivo CRISPR/Cas9 screen, we identify the non-canonical initiation factor eIF4G2 (DAP5/NAT1) as a translational checkpoint restraining...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 92beb5d0-38e6-5d8c-90da-9fc660e078cc
- DOI
- 10.64898/2026.03.14.711799
